{
     "PMID": "20829454",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20101102",
     "LR": "20161122",
     "IS": "1095-9203 (Electronic) 0036-8075 (Linking)",
     "VI": "330",
     "IP": "6001",
     "DP": "2010 Oct 8",
     "TI": "Tau reduction prevents Abeta-induced defects in axonal transport.",
     "PG": "198",
     "LID": "10.1126/science.1194653 [doi]",
     "AB": "Amyloid-beta (Abeta) peptides, derived from the amyloid precursor protein, and the microtubule-associated protein tau are key pathogenic factors in Alzheimer's disease (AD). How exactly they impair cognitive functions is unknown. We assessed the effects of Abeta and tau on axonal transport of mitochondria and the neurotrophin receptor TrkA, cargoes that are critical for neuronal function and survival and whose distributions are altered in AD. Abeta oligomers rapidly inhibited axonal transport of these cargoes in wild-type neurons. Lowering tau levels prevented these defects without affecting baseline axonal transport. Thus, Abeta requires tau to impair axonal transport, and tau reduction protects against Abeta-induced axonal transport defects.",
     "FAU": [
          "Vossel, Keith A",
          "Zhang, Kai",
          "Brodbeck, Jens",
          "Daub, Aaron C",
          "Sharma, Punita",
          "Finkbeiner, Steven",
          "Cui, Bianxiao",
          "Mucke, Lennart"
     ],
     "AU": [
          "Vossel KA",
          "Zhang K",
          "Brodbeck J",
          "Daub AC",
          "Sharma P",
          "Finkbeiner S",
          "Cui B",
          "Mucke L"
     ],
     "AD": "Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA. kvossel@gladstone.ucsf.edu",
     "LA": [
          "eng"
     ],
     "GR": [
          "K99 NS057906/NS/NINDS NIH HHS/United States",
          "NS057906/NS/NINDS NIH HHS/United States",
          "R01 AG011385/AG/NIA NIH HHS/United States",
          "NS041787/NS/NINDS NIH HHS/United States",
          "R01 NS041787/NS/NINDS NIH HHS/United States",
          "R00 NS057906/NS/NINDS NIH HHS/United States",
          "AG011385/AG/NIA NIH HHS/United States",
          "R00 NS057906-05/NS/NINDS NIH HHS/United States",
          "R01 AG011385-07/AG/NIA NIH HHS/United States",
          "R01 NS041787-09/NS/NINDS NIH HHS/United States",
          "R37 AG011385/AG/NIA NIH HHS/United States",
          "C06 RR018928/RR/NCRR NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20100909",
     "PL": "United States",
     "TA": "Science",
     "JT": "Science (New York, N.Y.)",
     "JID": "0404511",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Peptide Fragments)",
          "0 (amyloid beta-protein (1-42))",
          "0 (tau Proteins)",
          "EC 2.7.10.1 (Receptor, trkA)"
     ],
     "SB": "IM",
     "MH": [
          "Amyloid beta-Peptides/*metabolism/pharmacology",
          "Animals",
          "*Axonal Transport",
          "Cells, Cultured",
          "Hippocampus/cytology",
          "Mice",
          "Mitochondria/metabolism",
          "Neurons/*metabolism",
          "Peptide Fragments/*metabolism/pharmacology",
          "Receptor, trkA/metabolism",
          "tau Proteins/*metabolism"
     ],
     "PMC": "PMC3024010",
     "MID": [
          "NIHMS251160"
     ],
     "EDAT": "2010/09/11 06:00",
     "MHDA": "2010/11/03 06:00",
     "CRDT": [
          "2010/09/11 06:00"
     ],
     "PHST": [
          "2010/09/11 06:00 [entrez]",
          "2010/09/11 06:00 [pubmed]",
          "2010/11/03 06:00 [medline]"
     ],
     "AID": [
          "science.1194653 [pii]",
          "10.1126/science.1194653 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Science. 2010 Oct 8;330(6001):198. doi: 10.1126/science.1194653. Epub 2010 Sep 9.",
     "term": "hippocampus"
}